Insights into the transcriptional and chromatin regulation of mesenchymal stem cells in musculo-skeletal tissues

Annals of Anatomy

Volumn 191, Issue 1, 2009, Pages 2-12

  Benayahu, Dafna ^a   Shefer, Gabi ^a   Shur, Irena ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Chromatin remodeling; Mesenchymal cell differentiation; Transcription regulation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; MYOD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ADULT STEM CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CHONDROGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; MESENCHYMAL STEM CELL; MUSCLE DEVELOPMENT; MUSCULOSKELETAL SYSTEM; MYOBLAST; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADULT; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CARTILAGE; CELL DIFFERENTIATION; CELL DIVISION; CHROMATIN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SKELETAL; TRANSCRIPTION, GENETIC;

EID: 58149194783     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2008.07.008     Document Type: Article

References (99)

1. Asakura A. Stem cells in adult skeletal muscle. Trends Cardiovasc. Med. 13 (2003) 123-128
2. Bailey P., Downes M., Lau P., Harris J., Chen S.L., Hamamori Y., Sartorelli V., and Muscat G.E. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13 (1999) 1155-1168
3. Benayahu D., Shur I., and Ben-Eliyahu S. Hormonal changes affect the bone and bone marrow cells in a rat model. J. Cell. Biochem. 79 3 (2000) 407-415
4. Benayahu D., Akavia U.D., and Shur I. Differentiation of bone marrow stroma-derived mesenchymal cells. Curr. Med. Chem. 14 (2007) 173-179
5. Benayahu D., Shefer G., and Shur I. Insights into chromatin remodelers in mesenchymal stem cells and differentiation. Front. Biosci. 14 (2008) 398-409
6. Berkes C.A., Bergstrom D.A., Penn B.H., Seaver K.J., Knoepfler P.S., and Tapscott S.J. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 14 (2004) 465-477
7. Bird A.P., and Wolffe A.P. Methylation-induced repression - belts, braces, and chromatin. Cell 99 (1999) 451-454
8. Blais A., van Oevelen C.J., Margueron R., Acosta-Alvear D., and Dynlacht B.D. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. J. Cell. Biol. 179 (2007) 1399-1412
9. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
10. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., and Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317 (2007) 807-810
11. Brennan T.J., and Olson E.N. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. 4 (1990) 582-595
12. Camarda G., Siepi F., Pajalunga D., Bernardini C., Rossi R., Montecucco A., Meccia E., and Crescenzi M. A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells. J. Cell. Biol. 167 (2004) 417-423
13. Caretti G., Di Padova M., Micales B., Lyons G.E., and Sartorelli V. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 18 (2004) 2627-2638
14. Choi K.Y., Kim H.J., Lee M.H., Kwon T.G., Nah H.D., Furuichi T., Komori T., Nam S.H., Kim Y.J., and Ryoo H.M. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev. Dyn. 233 (2005) 115-121
15. Cobrinik D., Lee M.H., Hannon G., Mulligan G., Bronson R.T., Dyson N., Harlow E., Beach D., Weinberg R.A., and Jacks T. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10 (1996) 1633-1644
16. Cossu G. Fusion of bone marrow-derived stem cells with striated muscle may not be sufficient to activate muscle genes. J. Clin. Invest. 114 (2004) 1540-1543
17. de Bruin A., Wu L., Saavedra H.I., Wilson P., Yang Y., Rosol T.J., Weinstein M., Robinson M.L., and Leone G. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc. Natl. Acad. Sci. USA 100 (2003) 6546-6551
18. de la Serna I.L., Ohkawa Y., and Imbalzano A.N. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet. 7 (2006) 461-473
19. Di Padova M., Caretti G., Zhao P., Hoffman E.P., and Sartorelli V. MyoD acetylation influences temporal patterns of skeletal muscle gene expression. J. Biol. Chem. 282 (2007) 37650-37659
20. Dilworth F.J., Seaver K.J., Fishburn A.L., Htet S.L., and Tapscott S.J. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation. Proc. Natl. Acad. Sci. USA 101 (2004) 11593-11598
21. Dobreva G., Chahrour M., Dautzenberg M., Chirivella L., Kanzler B., Farinas I., Karsenty G., and Grosschedl R. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125 (2006) 971-986
22. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
23. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., and Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13 (1999) 1025-1036
24. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., and Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
25. Friedenstein A.J., Piatetzky II S., and Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16 (1966) 381-390
26. Galindo M., Pratap J., Young D.W., Hovhannisyan H., Im H.J., Choi J.Y., Lian J.B., Stein J.L., Stein G.S., and van Wijnen A.J. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 280 (2005) 20274-20285
27. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., Javed A., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280 (2005) 33132-33140
28. Gerber A.N., Klesert T.R., Bergstrom D.A., and Tapscott S.J. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11 (1997) 436-450
29. Gregory C.A., Gunn W.G., Reyes E., Smolarz A.J., Munoz J., Spees J.L., and Prockop D.J. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann. NY Acad. Sci. 1049 (2005) 97-106
30. Gu W., Schneider J.W., Condorelli G., Kaushal S., Mahdavi V., and Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72 (1993) 309-324
31. Guo K., Wang J., Andres V., Smith R.C., and Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15 (1995) 3823-3829
32. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., and Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
33. Gutierrez S., Javed A., Tennant D.K., van Rees M., Montecino M., Stein G.S., Stein J.L., and Lian J.B. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277 (2002) 1316-1323
34. Gyorgy A.B., Szemes M., de Juan Romero C., Tarabykin V., and Agoston D.V. SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur. J. Neurosci. 27 4 (2008) 865-873
35. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., and Lassar A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 (1995) 1018-1021
36. Hanai J., Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.Y., Guo W.H., Imamura T., Ishidou Y., Fukuchi M., Shi M.J., Stavnezer J., Kawabata M., Miyazono K., and Ito Y. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274 (1999) 31577-31582
37. Hassan M.Q., Tare R., Lee S.H., Mandeville M., Weiner B., Montecino M., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol. Cell. Biol. 27 (2007) 3337-3352
38. Huh M.S., Parker M.H., Scime A., Parks R., and Rudnicki M.A. Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J. Cell. Biol. 166 (2004) 865-876
39. Javed A., Gutierrez S., Montecino M., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol. Cell. Biol. 19 (1999) 7491-7500
40. Javed A., Guo B., Hiebert S., Choi J.Y., Green J., Zhao S.C., Osborne M.A., Stifani S., Stein J.L., Lian J.B., van Wijnen A.J., and Stein G.S. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J. Cell. Sci. 113 Pt 12 (2000) 2221-2231
41. Kilbey A., Blyth K., Wotton S., Terry A., Jenkins A., Bell M., Hanlon L., Cameron E.R., and Neil J.C. Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res. 67 23 (2007) 11263-11271
42. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
43. Komori T.J. Regulation of osteoblast differentiation by transcription factors. Cell Biochem. 99 5 (2006) 1233-1239
44. Krishnan V., Bryant H.U., and Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116 (2006) 1202-1209
45. LaBarge M.A., and Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111 (2002) 589-601
46. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., and Young D.W. Networks and hubs for the transcriptional control of osteo-blastogenesis. Rev. Endocr. Metab. Disord. 7 (2006) 1-16
47. Liu S., Spinner D.S., Schmidt M.M., Danielsson J.A., Wang S., and Schmidt J. Interaction of MyoD family proteins with enhancers of acetylcholine receptor subunit genes in vivo. J. Biol. Chem. 275 (2000) 41364-41368
48. Long M.A., Corbel S.Y., and Rossi F.M. Circulating myogenic progenitors and muscle repair. Semin. Cell Dev. Biol. 16 (2005) 632-640
49. Mal A., and Harter M.L. MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 1735-1739
50. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., and Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. Embo J. 20 (2001) 1739-1753
51. Marom R., Shur I., Hager G.L., and Benayahu D. Expression and regulation of CReMM, a chromodomain helicase-DNA-binding (CHD), in marrow stroma derived osteoprogenitors. J. Cell. Physiol. 207 (2006) 628-635
52. McKinsey T.A., Zhang C.L., and Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11 (2001) 497-504
53. Molkentin J.D., and Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93 (1996) 9366-9373
54. Montecino M., Pockwinse S., Lian J., Stein G., and Stein J. DNase I hypersensitive sites in promoter elements associated with basal and vitamin D dependent transcription of the bone-specific osteocalcin gene. Biochemistry 33 (1994) 348-353
55. Mundy G.R., and Elefteriou F. Boning up on ephrin signaling. Cell 126 (2006) 441-443
56. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., and Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
57. Palacios D., and Puri P.L. The epigenetic network regulating muscle development and regeneration. J. Cell. Physiol. 207 (2006) 1-11
58. Paredes R., Gutierrez J., Gutierrez S., Allison L., Puchi M., Imschenetzky M., van Wijnen A., Lian J., Stein G., Stein J., and Montecino M. Interaction of the 1alpha, 25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochem. J. 363 (2002) 667-676
59. Peschiaroli A., Figliola R., Coltella L., Strom A., Valentini A., D'Agnano I., and Maione R. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus. Oncogene 21 (2002) 8114-8127
60. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
61. Polesskaya A., and Harel-Bellan A. Acetylation of MyoD by p300 requires more than its histone acetyltransferase domain. J. Biol. Chem. 276 (2001) 44502-44503
62. Polesskaya A., Naguibneva I., Fritsch L., Duquet A., Ait-Si-Ali S., Robin P., Vervisch A., Pritchard L.L., Cole P., and Harel-Bellan A. CBP/p300 and muscle differentiation: no HAT, no muscle. Embo J. 20 (2001) 6816-6825
63. Pratap J., Javed A., Languino L.R., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25 (2005) 8581-8591
64. Puri P.L., and Sartorelli V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell. Physiol. 185 (2000) 155-173
65. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y., and Levrero M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1 (1997) 35-45
66. Puri P.L., Iezzi S., Stiegler P., Chen T.T., Schiltz R.L., Muscat G.E., Giordano A., Kedes L., Wang J.Y., and Sartorelli V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell 8 (2001) 885-897
67. Rodda S.J., and McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133 (2006) 3231-3244
68. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., and Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4 (1999) 725-734
69. Seaberg R.M., and van der Kooy D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci. 26 (2003) 125-131
70. Sekiya I., Larson B.L., Vuoristo J.T., Cui J.G., and Prockop D.J. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J. Bone Miner. Res. 19 (2004) 256-264
71. Shefer G., and Yablonka-Reuveni Z. Reflections on lineage potential of skeletal muscle satellite cells: do they sometimes go MAD?. Crit. Rev. Eukaryot. Gene Expression 17 (2007) 13-22
72. Shefer G., Wleklinski-Lee M., and Yablonka-Reuveni Z. Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J. Cell Sci. 117 (2004) 5393-5404
73. Shefer G., Carmeli E., Rauner G., Yablonka-Reuveni Z., and Benayahu D. Exercise running and tetracycline as means to enhance skeletal muscle stem cell performance after external fixation. J. Cell. Physiol. 215 (2008) 265-275
74. Shen J., Hovhannisyan H., Lian J.B., Montecino M.A., Stein G.S., Stein J.L., and Van Wijnen A.J. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol. Endocrinol. 17 (2003) 743-756
75. Sherwood R.I., Christensen J.L., Conboy I.M., Conboy M.J., Rando T.A., Weissman I.L., and Wagers A.J. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119 (2004) 543-554
76. Shostak S. (Re)defining stem cells. Bioessays 28 (2006) 301-308
77. Shur I., and Benayahu D. Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein. J. Mol. Biol. 352 (2005) 646-655
78. Shur I., Socher R., and Benayahu D. In vivo association of CReMM/CHD9 with promoters in osteogenic cells. J. Cell. Physiol. 207 (2006) 374-378
79. Shur I., Solomon R., and Benayahu D. Dynamic interactions of chromatin-related mesenchymal modulator, a chromodomain helicase-DNA-binding protein, with promoters in osteoprogenitors. Stem Cells 24 (2006) 1288-1293
80. Sierra O.L., Cheng S.L., Loewy A.P., Charlton-Kachigian N., and Towler D.A. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element. J. Biol. Chem. 279 (2004) 32913-32923
81. Simone C., Forcales S.V., Hill D.A., Imbalzano A.N., Latella L., and Puri P.L. p38 pathway targets SWI-SNF chromatin-remodelling complex to muscle-specific loci. Nat. Genet. 36 (2004) 738-743
82. Stein G.S., Lian J.B., van Wijnen A.J., and Stein J.L. The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol. Biol. Rep. 24 (1997) 185-196
83. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., Zaidi S.K., Young D.W., Choi J.Y., and Pockwinse S.M. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23 (2004) 4315-4329
84. Surapureddi S., Viswakarma N., Yu S., Guo D., Rao M.S., and Reddy J.K. PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. Biochem. Biophys. Res. Commun. 343 (2006) 535-543
85. Tapscott S.J. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132 (2005) 2685-2695
86. Tapscott S.J., Davis R.L., Thayer M.J., Cheng P.F., Weintraub H., and Lassar A.B. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242 (1988) 405-411
87. Villagra A., Gutierrez J., Paredes R., Sierra J., Puchi M., Imschenetzky M., Wijnen Av A., Lian J., Stein G., Stein J., and Montecino M. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J. Cell. Biochem. 85 (2002) 112-122
88. Villagra A., Cruzat F., Carvallo L., Paredes R., Olate J., van Wijnen A.J., Stein G.S., Lian J.B., Stein J.L., Imbalzano A.N., and Montecino M. Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J. Biol. Chem. 281 (2006) 22695-22706
89. Weintraub H., Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., and Miller A.D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86 (1989) 5434-5438
90. Weston A.D., Hoffman L.M., and Underhill T.M. Revisiting the role of retinoid signaling in skeletal development. Birth Defects Res. C Embryo Today 69 (2003) 156-173
91. Wu L., de Bruin A., Saavedra H.I., Starovic M., Trimboli A., Yang Y., Opavska J., Wilson P., Thompson J.C., Ostrowski M.C., Rosol T.J., Woollett L.A., Weinstein M., Cross J.C., Robinson M.L., and Leone G. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421 (2003) 942-947
92. Yahi H., Philipot O., Guasconi V., Fritsch L., and Ait-Si-Ali S. Chromatin modification and muscle differentiation. Expert Opin. Ther. Targets 10 (2006) 923-934
93. Young D.W., Pratap J., Javed A., Weiner B., Ohkawa Y., van Wijnen A., Montecino M., Stein G.S., Stein J.L., Imbalzano A.N., and Lian J.B. SWI/SNF chromatin remodelling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J. Cell. Biochem. 94 (2005) 720-730
94. Young D.W., Hassan M.Q., Yang X.Q., Galindo M., Javed A., Zaidi S.K., Furcinitti P., Lapointe D., Montecino M., Lian J.B., Stein J.L., van Wijnen A.J., and Stein G.S. Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc. Natl. Acad. Sci. USA 104 9 (2007) 3189-3194
95. Young D.W., Hassan M.Q., Pratap J., Galindo M., Zaidi S.K., Lee S.H., Yang X., Xie R., Javed A., Underwood J.M., Furcinitti P., Imbalzano A.N., Penman S., Nickerson J.A., Montecino M.A., Lian J.B., Stein J.L., van Wijnen A.J., and Stein G.S. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445 7126 (2007) 442-446
96. Zaidi S.K., Sullivan A.J., Medina R., Ito Y., van Wijnen A.J., Stein J.L., Lian J.B., and Stein G.S. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. Embo J. 23 (2004) 790-799
97. Zammit P.S., Partridge T.A., and Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54 (2006) 1177-1191
98. Zelzer E., Glotzer D.J., Hartmann C., Thomas D., Fukai N., Soker S., and Olsen B.R. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106 (2001) 97-106
99. Zipori D. The nature of stem cells: state rather than entity. Nat. Rev. Genet. 5 (2004) 873-878